Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 168,412 | 21,766 | N/A |
| Marketable Securities | 222,385 | 120,096 | N/A |
| Other current assets | 6,272 | 10,632 | 0 |
| TOTAL | $397,069 | $152,494 | $N/A |
| Non-Current Assets | |||
| PPE Net | 21 | 22 | N/A |
| Other Non-Current Assets | 266 | 103 | 0 |
| TOTAL | $287 | $125 | $N/A |
| Total Assets | $397,356 | $152,619 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,071 | 2,126 | 0 |
| Accrued Expenses | 5,606 | 6,979 | N/A |
| Other current liabilities | 39 | 47 | N/A |
| TOTAL | $6,716 | $9,152 | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 264,481 | 0 |
| TOTAL | $N/A | $264,481 | $N/A |
| Total Liabilities | $6,716 | $273,633 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 41,779 | N/A | N/A |
| Common Shares | 1 | 1 | N/A |
| Retained earnings | -150,653 | -123,421 | N/A |
| Other shareholders' equity | -1,752 | 60 | 0 |
| TOTAL | $390,640 | $-121,014 | $N/A |
| Total Liabilities And Equity | $397,356 | $152,619 | $0 |